~form-bio-8668
How can AI and machine learning models increase yield, safety, and efficiency of pre-clinical manufacturing?
What is the challenge of construct truncation in viral vector manufacturability?
What are the potential benefits of applying innovative AI solutions to pre-clinical cell and gene therapy development?
How does Form Bio help biology teams save time and maximize research?
What are the barriers to high-yield production of viral vectors in cell and gene therapy development?
How can AI predict and optimize construct design for real-world manufacturing in gene therapies?
Who is hosting the webinar on next-gen cell and gene therapy manufacturing?
Which organization did Form Bio join forces with for a live discussion on rare disease research and development?
What are the challenges in affecting life-changing care for rare disease families?
How will the use of deep learning impact cell and gene therapies?
What is CRISPRank and what does it enable scientists to do?
What is the purpose of the white paper on gene therapy manufacturing failures?
What is FLAG and what does it do?
Who is the Chief Scientific Officer of Solid Biosciences?
What is the purpose of Form Bio's FORMsight technology?
